“Anakinra As Rescue Therapy to Treat Patients With Severe COVID-19 Refractory to Tocilizumab”. 2021. Archives of Clinical and Biomedical Research 5 (6): 972-82. https://fortunejournals.org/ojs/index.php/acbr/article/view/14882.